ochratoxin a has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, T; Bhat, PV; Khanum, F; Mohan Manu, T | 1 |
| Reunova, O; Sanchez-Ramos, J; Sava, V; Velasquez, A | 1 |
2 other study(ies) available for ochratoxin a and Parkinsonian Disorders
| Article | Year |
|---|---|
Restorative effect of l-Dopa treatment against Ochratoxin A induced neurotoxicity.
Topics: Animals; Antiparkinson Agents; Carcinogens; Levodopa; Male; Mice; Mice, Inbred BALB C; Motor Activity; Ochratoxins; Parkinsonian Disorders; Random Allocation; Treatment Outcome | 2018 |
Can low level exposure to ochratoxin-A cause parkinsonism?
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Age of Onset; Animals; Antioxidants; Carcinogens; Corpus Striatum; Disease Models, Animal; DNA Glycosylases; DNA Repair; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Male; Mice; Mice, Inbred ICR; Ochratoxins; Oxidative Stress; Parkinsonian Disorders; Up-Regulation | 2006 |